Please provide your email address to receive an email when new articles are posted on . DORC International has received FDA 510(k) clearance for Eva Nexus, the first surgical system cleared for ...
Please provide your email address to receive an email when new articles are posted on . FORT LAUDERDALE, Fla. — Best practices for safe subretinal delivery of gene therapy were presented at the Retina ...
Majority of patients demonstrated successful efficacy readouts across structural measurements (foveal schisis closure) and had meaningful improvement on visual function measurements including MP, BCVA ...
Good partnership working is essential for combination therapy companies who intend to use contract development and manufacturing organizations (CDMO). That’s according to Robert Farra, CTO at ...
When the FDA approved Spark Therapeutics’ Luxturna in December 2017, gene therapy became a household concept. Chatter about gene therapy curing blindness became hot fodder at dinner tables and ...
DURHAM, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback